James Hassard
Corporate Officer/Principal chez CRINETICS PHARMACEUTICALS, INC.
Fortune : 1 M $ au 30/04/2024
Profil
James Hassard is currently the Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. He previously held the position of Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. from 2020 to 2021.
Prior to that, he was the Vice President-Marketing at Medivation LLC (California) and the General Manager at Amgen BIO Farmaceutica Ltda.
From 2016 to 2020, he served as the Senior Vice President-Marketing & Market Access at Coherus BioSciences, Inc. Mr. Hassard holds an MBA from Nova Southeastern University, Inc. and an undergraduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2024 | 29 259 ( 0,04% ) | 1 M $ | 30/04/2024 |
Postes actifs de James Hassard
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2022 |
Anciens postes connus de James Hassard
| Sociétés | Poste | Fin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/08/2021 |
| COHERUS BIOSCIENCES, INC. | Sales & Marketing | 01/01/2020 |
| Amgen BIO Farmaceutica Ltda | Corporate Officer/Principal | - |
| MEDIVATION INC | Sales & Marketing | - |
Formation de James Hassard
| Nova Southeastern University, Inc. | Masters Business Admin |
| University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
| Amgen BIO Farmaceutica Ltda |
